ÂÜÀòÂÒÂ×

Nate Fishkin has a background in Chemistry and Biochemistry, with experience in various senior leadership roles in the pharmaceutical industry. Nate is currently serving as Senior Vice President at Modifi Bio, specializing in Drug Discovery and Early Development. Prior to this, Nate held positions at Orum Therapeutics, H3 Biomedicine, and ImmunoGen, Inc., where Nate led teams in developing technologies for antibody drug conjugates. Nate holds a PhD in Organic Chemistry from Columbia University.